Optimal duration of dual antiplatelet therapy after stent implantation in patients with or without diabetes.
Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria 3000, Australia Jocasta.Ball@acu.edu.au.
Jocasta
J
Ball
D001241:Aspirin; D003920:Diabetes Mellitus / Q000188:drug therapy; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin